Causeway Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.6M | Buy |
953,448
+95,561
| +11% | +$6.68M | 1.05% | 16 |
|
|
2025
Q1 | $63.1M | Buy |
857,887
+26,017
| +3% | +$1.91M | 1.32% | 18 |
|
|
2024
Q4 | $54.5M | Buy |
831,870
+341,431
| +70% | +$22.4M | 1.24% | 20 |
|
|
2024
Q3 | $38.2M | Buy |
490,439
+39,851
| +9% | +$3.1M | 0.94% | 33 |
|
|
2024
Q2 | $35.1M | Sell |
450,588
-45,888
| -9% | -$3.58M | 0.96% | 36 |
|
|
2024
Q1 | $33.6M | Buy |
496,476
+35,754
| +8% | +$2.42M | 0.88% | 36 |
|
|
2023
Q4 | $31M | Buy |
460,722
+105,501
| +30% | +$7.11M | 0.79% | 40 |
|
|
2023
Q3 | $24.1M | Buy |
355,221
+90,875
| +34% | +$6.15M | 0.63% | 42 |
|
|
2023
Q2 | $18.9M | Sell |
264,346
-59,357
| -18% | -$4.25M | 0.5% | 48 |
|
|
2023
Q1 | $22.5M | Buy |
323,703
+35,083
| +12% | +$2.44M | 0.54% | 36 |
|
|
2022
Q4 | $19.6M | Sell |
288,620
-15,993
| -5% | -$1.08M | 0.57% | 45 |
|
|
2022
Q3 | $16.7M | Sell |
304,613
-29,284
| -9% | -$1.61M | 0.47% | 49 |
|
|
2022
Q2 | $22.1M | Sell |
333,897
-74,258
| -18% | -$4.91M | 0.55% | 41 |
|
|
2022
Q1 | $27.1M | Buy |
408,155
+77,683
| +24% | +$5.15M | 0.65% | 39 |
|
|
2021
Q4 | $19.3M | Sell |
330,472
-16,539
| -5% | -$963K | 0.42% | 49 |
|
|
2021
Q3 | $20.8M | Buy |
347,011
+177,228
| +104% | +$10.6M | 0.47% | 49 |
|
|
2021
Q2 | $10.2M | Buy |
+169,783
| New | +$10.2M | 0.21% | 67 |
|